Clinical trial
Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease (COPD) and During Acute Exacerbations of COPD (AECOPD), in Asia Pacific
NCT03151395 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease (COPD) and During Acute Exacerbations of COPD (AECOPD), in Asia Pacific
- Lead sponsor
- GlaxoSmithKline
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 25, 2017
- Completion date
- April 6, 2020
- Enrollment
- 197 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory disorders